Showing 1 - 20 results of 503 for search '(( b non decrease ) OR ((( 50 ((a decrease) OR (_ decrease)) ) OR ( _ pd decrease ))))*', query time: 0.24s Refine Results
  1. 1

    Quality improvement can decrease blood delivery turnaround time: Evidence from a single tertiary-care academic medical center by Hammad Y.A.

    Published 2018
    “…The transport time significantly decreased from an initial majority of > 15 mins duration, to a majority of < 15 mins transport time after the second audit; there was a 50% improvement in 30 mins response time; and the percentage of requests processed in < 10 mins were significantly higher after the second audit. …”
    Get full text
  2. 2
  3. 3
  4. 4
  5. 5

    Antiferromagnetism in EuPdGe3 by Albedah, M.A.

    Published 2014
    “…The results of X-ray diffraction, magnetic susceptibility and magnetization, and 151Eu Mössbauer spectroscopy measurements of polycrystalline EuPdGe3 are reported. EuPdGe3 crystallizes in the BaNiSn3-type tetragonal structure (space group I4mm) with the lattice constants a=4.4457(1)Å and c=10.1703(2)Å. …”
    Get full text
    Get full text
  6. 6

    Quantification of the growth suppression of HER2+ breast cancer colonies under the effect of trastuzumab and PD-1/PD-L1 inhibitor. by Padmanabhan, Regina

    Published 2022
    “…Nevertheless, further studies are imperative to substantiate this argument and to uncover the potential crosstalk between PD-1/PD-L1 inhibitors and HER2 growth signaling pathways in breast cancer.…”
    Get full text
    Get full text
  7. 7

    Mycoplasma bovis-induced inhibition of bovine peripheral blood mononuclear cell proliferation is ameliorated after blocking the immune-inhibitory programmed death 1 receptor by Suleman M.

    Published 2018
    “…We demonstrated that M. bovis infection induced a significant decrease in CD4+ PD-1INT and CD8+ PD-1INT subsets with intermediate PD-1 expression, which functioned as progenitor pools giving rise to CD4+ PD-1HIGH and CD8+ PD-1HIGH subsets with high PD-1 expression levels. …”
    Get full text
    Get full text
  8. 8

    In vitro evaluation of Neosetophomone B inducing apoptosis in cutaneous T cell lymphoma by targeting the FOXM1 signaling pathway by Kuttikrishnan, Shilpa

    Published 2023
    “…Notably, higher expression levels of these genes showed reduced overall and progression-free survival in the CTCL patient cohort. FOXM1 and BUB1B expression exhibited a dose-dependent reduction in NSP-B-treated CTCL cells.FOXM1 silencing decreased cell viability and increased apoptosis via BUB1B downregulation. …”
    Get full text
    Get full text
  9. 9

    Molecular and Peritoneal Microvascular Changes Cause Peritoneal Membrane Dysfunction by Uremia-Related Mechanisms by Zakaria, El-Rasheid

    Published 2016
    “…These changes were assumed to be the cause for peritoneal membrane dysfunction and technique failure that was observed in some long-term PD patients. However, this assumption was refuted by the findings from animal models of chronic PD that showed the exact structural phenotype of the long-term PD, and yet a normal peritoneal function. …”
    Get full text
    Get full text
  10. 10

    Biocorrosion behavior of biodegradable nanocomposite fibers coated layer-by-layer on AM50 magnesium implant by Abdal-hay, Abdalla

    Published 2016
    “…The results showed that the AJS 3D membrane fiber layers, particularly the hybrid membrane layers containing a small amount of nHA (3wt.%), induce a higher biocorrosion resistance and effectively decrease the initial degradation rate compared with the neat AM50 coupon samples. …”
    Get full text
    Get full text
  11. 11

    Novel, selective EPO receptor ligands lacking erythropoietic activity reduce infarct size in acute myocardial infarction in rats by Kiss, K.

    Published 2016
    “…Therefore, non-erythropoietic EPO receptor peptide ligands may be promising cardioprotective agents.…”
    Get full text
    Get full text
  12. 12

    The mitochondrial-related effect of the 905 nm photobiomodulation therapy on 50B11 sensory neurons by Zupin, Luisa

    Published 2023
    “…In this study, a possible molecular mechanism of the 905 nm PBMT (0.25 W/cm2; 3, 6, 12, and 18 J/cm2, 5 Hz) analgesic effect was tested on 50B11 cells, by investigating its impact on mitochondria. …”
    Get full text
    Get full text
    Get full text
  13. 13

    Modification of Pd/CeO2 catalyst by Atomic Layer Deposition of ZrO2 by Onn, Tzia Ming

    Published 2016
    “…Calcination of the unmodified Pd/CeO2, prepared by precipitation of aqueous Ce(NO3)3 solutions, with Pd added by impregnation, caused a large decrease in surface area and an increase in crystallite size between 673 K and 1073 K; however, catalysts modified by 0.4 nm ZrO2 films showed no change in either surface area or CeO2 crystallite size upon calcination to 1073 K. …”
    Get full text
    Get full text
  14. 14
  15. 15
  16. 16

    Pd nanocrystals encapsulated in MOF-derived Ni/N-doped hollow carbon nanosheets for efficient thermal CO oxidation: unveiling the effect of porosity by Ipadeola, Adewale K.

    Published 2023
    “…Conspicuously, the T100 of Pd/Ni-MOF-HNC was lower than those of most previously reported Pd-based catalysts due to the high porosity, surface area, and electronic interaction of Pd/Ni-Nx, and Ni-metal defects, which promote the adsorption/activation of reactants (CO + O2), decrease the activation energy to 73.1 kJ mol−1 and enhance the reaction rate at the same CO conversion percentage. …”
    Get full text
    Get full text
    Get full text
  17. 17
  18. 18

    Protein arginine methyltransferase 5 (PRMT5) promotes survival of lymphoma cells via activation of WNT/B-catenin and AKT/GSK3B proliferative signaling by Chung, Jihyun

    Published 2019
    “…In this report, we investigate the relationship between PRMT5 and WNT/B- CATENIN as well as AKT/GSK3B proliferative signaling in three different types of non-Hodgkin's lymphoma cell lines, clinical samples, and mouse primary lymphoma cells. …”
    Get full text
    Get full text
  19. 19

    Molecular insights of the G2019S substitution in LRRK2 kinase domain associated with Parkinson's disease: A molecular dynamics simulation approach. by Agrahari, Ashish Kumar

    Published 2019
    “…The G2019S substitution in the Leucine-rich repeat kinase 2 (LRRK2) is significantly associated with Parkinson's disease (PD). This substitution was identified in both familial and sporadic forms of PD with a higher frequency. …”
    Get full text
    Get full text
  20. 20